AT383337T

1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)

Abstract

Compound of formula I: or a pharmaceutically acceptable salt thereof; wherein: the dotted line between Y and Z represents an optional double bond; the dotted line between the two R4 groups represents an optional heterocyclic ring of 4 to 6 ring atoms that may be formed between the two R4 groups, together with the nitrogen through which they are attached; Y is N, CR6 or C = O; Z is N, NR7, CR5 or C (R5) 2; R1 is, independently at each occurrence, alkyl, alkoxy, halo, CF3, OCF3, arylalkyloxy substituted with 0 to 3 R11, aryloxy substituted with 0 to 3 R11, aryl substituted with 0 to 3 R11, heteroaryl substituted with 0 to 3 R11, hydroxy, alkanoyloxy, nitro, nitrile, alkenyl, alkynyl, alkyl sulfoxide, dimethyl phenyl substituted with 0 to 3 R11, alkylsulfone, phenylsulfone substituted with 0 to 3 R11, alkylsulfonamide, phenylsulfonamide substituted with 0 to 3 R11, heteroaryloxy substituted with 0 to 3 R11, I heteroarilmetiloxi substituted with 0 to 3 R11, alkylamido, or arylamido substituted con0 I to 3 R11; or two adjacent R1 also represent methylenedioxy; R2 is aryl substituted with 0 to 3 R1, or heteroaryl substituted with 0 to 3 R1; R3 is H or C1-C4 alkyl; R4 is, independently each occurrence, H, C1-C4 alkyl, arylalkyl, heteroarylmethyl, cycloheptylmethyl, cyclohexylmethyl, cyclopentylmethyl or cyclobutylmethyl, or both R4 groups together with the nitrogen through which they are attached form a heterocyclic ring of 4 to 6 atoms ring, wherein one carbon may be optionally substituted with N, O, S or SO2, and wherein any ring carbon atom or N atom a further optionally substituted with alkyl may C1-C4 alkyl, F or CF3; R5 is, independently each occurrence, H, C1-C4 alkyl, aryl substituted with 0 to 3 R1, or cyano; or two R5 when present, form a carbocyclic ring of 3 to 7 carbons; R6 is H, C1-C4 alkyl or cyano; R7 is H, C1-C6 alkyl, C3-C6 cycloalkyl or aryl substituted with 0 to 3 R1; R8 is H or C1-C4 alkyl; R9 is H or C1-C4 alkyl; R10 is, independently at each occurrence, H or C1-C4 alkyl; or R10 and R4 together with the nitrogen to which R4 is attached form a nitrogen containing ring of 3 to 6 carbon atoms; n is an integer from 0 to 4; x is an integer from 1 to 2; and R11 is alkyl, alkoxy, halo, CF3, OCF3, hydroxy, alkanoyloxy, nitro, nitrile, alkenyl, alkynyl, alkyl sulfoxide, alkylsulfone, alkylsulfonamide, or alkylamido; or two adjacent R11 also represent methylenedioxy; wherein 1 to 3 carbon atoms in ring A may optionally be substituted with N.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

30 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
55765104United States of AmericaP
56986304United States of AmericaP
9188505United States of AmericaA

Members30

Family members, oldest first
DocumentOfficeKind
US2005222148A1United States of AmericaA1
AU2005230900A1AustraliaA1
CA2560967A1CanadaA1
WO2005097744A1World Intellectual Property Organization (WIPO)A1
TW200536532ATaiwan Province of ChinaA
PA8628001A1PanamaA1
AR048675A1ArgentinaA1
PE20060288A1PeruA1
SV2006002068AEl SalvadorA
ECSP066899AEcuadorA
NO20064892LNorwayL
EP1732887A1European Patent Office (EPO)A1
KR20060134186ARepublic of KoreaA
IL178185D0IsraelD0
CN1960973AChinaA
CR8639ACosta RicaA
BRPI0509390ABrazilA
JP2007531751AJapanA
EP1732887B1European Patent Office (EPO)B1
AT383337TThis recordAustriaT
DE602005004268D1GermanyD1
DK1732887T3DenmarkT3
RU2006134012ARussian FederationA
ES2299025T3SpainT3
PL1732887T3PolandT3
ZA200608134BSouth AfricaB
DE602005004268T2GermanyT2
US2009093469A1United States of AmericaA1
US7517899B2United States of AmericaB2
US2009099164A1United States of AmericaA1